On Tuesday, Israel approved the use of Gilead Sciences Inc’s antiviral drug remdesivir for the treatment of patients with COVID-19 infection.
In a statement, Prime Minister Benjamin Netanyahu’s office said his cabinet agreed to the health minister’s request to accept Gilead’s donation of remdesivir and that it would be used to treat moderately and critically ill patients.
Remdesivir is the first drug shown to be effective against the novel coronavirus in human trials, with South Korea, Japan, India, the United States and Singapore having already approved it for emergency use.